NOVABONE PRODUCTS, LLC

NovaBone Products, LLC is a medical technology company specializing in bioactive glass-based biomaterials, bone grafts, and regenerative biologics for orthopedic and dental applications. Founded in 2002 and based in Alachua, Florida, the company has over 20 years of experience developing osteobiologic products. NovaBone's proprietary bioactive glass formulations are clinically proven to signal genetic pathways for bone formation, recruit osteoprogenitor stem cells, and regulate the osteoblast cycle to favor bone-forming cell proliferation and differentiation. The company manufactures synthetic bone graft substitutes and collagen matrix delivery systems in putty and syringe formats tailored for orthopedic surgeons and dental practitioners. NovaBone's solutions address diverse surgical requirements including tibial cyst filling, sinus grafting, and partial extraction therapy. With millions of devices deployed globally and backed by extensive clinical research, NovaBone was acquired by Halma plc in 2020 to enhance distribution and regulatory capabilities worldwide.